Deborah Casso

670 total citations
16 papers, 468 citations indexed

About

Deborah Casso is a scholar working on Oncology, Economics and Econometrics and Immunology. According to data from OpenAlex, Deborah Casso has authored 16 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Economics and Econometrics and 3 papers in Immunology. Recurrent topics in Deborah Casso's work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Erythrocyte Function and Pathophysiology (2 papers) and Blood disorders and treatments (2 papers). Deborah Casso is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (3 papers), Erythrocyte Function and Pathophysiology (2 papers) and Blood disorders and treatments (2 papers). Deborah Casso collaborates with scholars based in United States, United Kingdom and Spain. Deborah Casso's co-authors include Stephen H. Taplin, Diana S.M. Buist, Emily White, Julie Hunt, Susan A. Oliveria, Marianne Ulcickas Yood, Joyce Gilbert, Kimberly Bischoff, M. Michele Manos and Laura Ichikawa and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Deborah Casso

16 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deborah Casso United States	10	240	72	62	58	56	16	468
Peh Joo Ho Singapore	13	408 1.7×	50 0.7×	49 0.8×	119 2.1×	64 1.1×	39	691
Iraj Asvadi Kermani Iran	13	253 1.1×	47 0.7×	113 1.8×	86 1.5×	23 0.4×	57	647
Diana T. Chingos United States	8	278 1.2×	58 0.8×	88 1.4×	117 2.0×	77 1.4×	8	516
Brionna Y. Hair United States	10	260 1.1×	36 0.5×	87 1.4×	38 0.7×	30 0.5×	25	498
Tiefu Shen United States	10	334 1.4×	75 1.0×	106 1.7×	113 1.9×	111 2.0×	14	662
Laura Venditti United States	8	340 1.4×	78 1.1×	58 0.9×	142 2.4×	92 1.6×	8	653
April Barbour United States	5	267 1.1×	149 2.1×	69 1.1×	72 1.2×	40 0.7×	7	494
Stefanie M. Thomas United States	15	119 0.5×	143 2.0×	111 1.8×	65 1.1×	35 0.6×	37	552
Ali Ghanbari Motlagh Iran	11	208 0.9×	31 0.4×	46 0.7×	61 1.1×	46 0.8×	51	405
Jill M. Oliveri United States	13	505 2.1×	68 0.9×	97 1.6×	50 0.9×	51 0.9×	23	647

Countries citing papers authored by Deborah Casso

Since Specialization

Citations

This map shows the geographic impact of Deborah Casso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Casso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Casso more than expected).

Fields of papers citing papers by Deborah Casso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Casso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Casso. The network helps show where Deborah Casso may publish in the future.

Co-authorship network of co-authors of Deborah Casso

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Casso. A scholar is included among the top collaborators of Deborah Casso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Casso. Deborah Casso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Solà-Morales, Oriol, Lesley H. Curtis, Deborah Casso, et al.. (2023). Effectively Leveraging RWD for External Controls: A Systematic Literature Review of Regulatory and HTA Decisions. Clinical Pharmacology & Therapeutics. 114(2). 325–355. 16 indexed citations

2.

Curtis, Lesley H., Oriol Solà-Morales, Patrick Saunders‐Hastings, et al.. (2023). Regulatory and HTA Considerations for Development of Real‐World Data Derived External Controls. Clinical Pharmacology & Therapeutics. 114(2). 303–315. 9 indexed citations

3.

Casso, Deborah, et al.. (2022). Assessing the incidence of osteosarcoma among teriparatide-treated patients using linkage of commercial pharmacy and state cancer registry data, contributing to the removal of boxed warning and other labeling changes. Bone. 160. 116394–116394. 5 indexed citations

4.

Tachdjian, Raffi, Karin Johnson, Deborah Casso, et al.. (2020). Real-world cohort study of adult and pediatric patients treated for hereditary angioedema in the United States. Allergy and Asthma Proceedings. 41(3). 172–182. 5 indexed citations

5.

Secrest, Matthew H., et al.. (2020). Prevalence of pyruvate kinase deficiency: A systematic literature review. European Journal Of Haematology. 105(2). 173–184. 32 indexed citations

6.

Tachdjian, Raffi, Karin Johnson, Deborah Casso, et al.. (2020). Real-world cohort study of adult and pediatric patients treated for hereditary angioedema in the United States. Allergy and Asthma Proceedings. 41(3). 172–182. 7 indexed citations

7.

Secrest, Matthew H., et al.. (2019). Prevalence of Red Cell Pyruvate Kinase Deficiency: A Systematic Literature Review. Blood. 134(Supplement_1). 3513–3513. 1 indexed citations

8.

Murage, Mwangi J., Amanda H. Anderson, Deborah Casso, et al.. (2018). Treatment patterns, adherence, and persistence among psoriasis patients treated with biologics in a real-world setting, overall and by disease severity. Journal of Dermatological Treatment. 30(2). 141–149. 25 indexed citations

9.

Murage, Mwangi J., Amanda H. Anderson, Susan A. Oliveria, et al.. (2018). Healthcare resource utilization and costs among psoriasis patients treated with biologics, overall and by disease severity. Journal of Medical Economics. 21(8). 745–754. 11 indexed citations

10.

Casso, Deborah, et al.. (2017). SA38. Assessment of Cognitive Impairment, Treatment Adherence, and Healthcare Resource Utilization Among Treated Schizophrenia Patients. Schizophrenia Bulletin. 43(suppl_1). S127–S127. 1 indexed citations

11.

Yood, Marianne Ulcickas, Michele Bortolini, Deborah Casso, et al.. (2015). Incidence of liver injury among cancer patients receiving chemotherapy in an integrated health system. Pharmacoepidemiology and Drug Safety. 24(4). 427–434. 14 indexed citations

12.

Chu, Laura, Marianne Ulcickas Yood, Mahmoud Loghman‐Adham, et al.. (2012). Renal impairment after chemotherapy in lung (LC), colorectal (CRC), and breast cancer (BC) patients (pts) from the Henry Ford Health System (HFHS) tumor registry.. Journal of Clinical Oncology. 30(15_suppl). 1590–1590. 3 indexed citations

13.

Taplin, Stephen H., Laura Ichikawa, Marianne Ulcickas Yood, et al.. (2004). Reason for Late-Stage Breast Cancer: Absence of Screening or Detection, or Breakdown in Follow-up?. JNCI Journal of the National Cancer Institute. 96(20). 1518–1527. 121 indexed citations

14.

Casso, Deborah, Diana S.M. Buist, & Stephen H. Taplin. (2004). Quality of life of 5-10 year breast cancer survivors diagnosed between age 40 and 49.. Health and Quality of Life Outcomes. 2(1). 25–25. 124 indexed citations

15.

Casso, Deborah, Emily White, Ruth E. Patterson, et al.. (2000). Correlates of Serum Lycopene in Older Women. Nutrition and Cancer. 36(2). 163–169. 25 indexed citations

16.

White, Emily, Julie Hunt, & Deborah Casso. (1998). Exposure Measurement in Cohort Studies: The Challenges of Prospective Data Collection. Epidemiologic Reviews. 20(1). 43–56. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact